New combo therapy aims to stop daytime accidents in kids
NCT ID NCT06551246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a combination of two drugs (solifenacin and mirabegron) at low doses works better than a high dose of either drug alone for children aged 5 to 14 with daytime wetting. About 236 children who did not fully respond to low-dose single drugs will be randomly assigned to one of four treatment groups for 18 weeks. The goal is to reduce the number of wet days per week.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY INCONTINENCE IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Pediatric and Adolescent Medicine, Aalborg University Hospital
RECRUITINGAalborg, Aalborg, 9000, Denmark
-
Department of Pediatric and Adolescent Medicine, Aarhus University Hospital
RECRUITINGAarhus, Aarhus N, 8200, Denmark
-
Department of Pediatric and Adolescent Medicine, Gødstrup Hospital
RECRUITINGHerning, Herning, 7400, Denmark
-
Department of Pediatric and Adolescent Medicine, Kolding Hospital
RECRUITINGKolding, Kolding, 6000, Denmark
-
Department of Pediatric and Adolescent medicine, Esbjerg Hospital
RECRUITINGEsbjerg, Esbjerg, 6700, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.